Related Experiment Video

Updated: May 4, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Is there an effect of menopause on CHD mortality? Asia Pacific comparisons

I K Robertson1, M J Bell

  • 1School of Nutrition and Public Health, Deakin University, Malvern, Melbourne, Victoria, and Centre for Health Program Evaluation, Monash University, West Heidelberg, Melbourne, Victoria, Australia.

Asia Pacific Journal of Clinical Nutrition
|January 8, 2014
PubMed

Insights

Men have higher coronary heart disease (CHD) mortality rates across Asia-Pacific nations. Post-menopausal women did not show a clear increase in CHD mortality, indicating menopause

Area of Science:

  • Cardiovascular epidemiology
  • Public health research
  • Gerontology

Background:

  • Coronary heart disease (CHD) presents varied incidence across Asia-Pacific countries.
  • Understanding gender-specific mortality trends in CHD is crucial for public health.
  • The impact of menopause on cardiovascular health requires further investigation.

Purpose of the Study:

  • To analyze and compare CHD mortality rates between men and women in diverse Asia-Pacific populations.
  • To investigate potential correlations between menopause and CHD mortality in women.

Main Methods:

  • Cross-sectional analysis of mortality data from multiple Asia-Pacific countries.
  • Stratification of CHD mortality rates by sex.
  • Statistical evaluation to detect changes in mortality rates related to menopausal status.

Main Results:

  • Consistently higher CHD mortality rates were observed in men compared to women across all studied countries.
  • No definitive increase in CHD mortality rates attributable to menopause was identified in women.

Conclusions:

  • Male sex is a significant risk factor for higher CHD mortality in the Asia-Pacific region.
  • Menopause does not appear to be a clear, independent determinant of increased CHD mortality in women within these populations.

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.6K

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
757
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K